Hims & Hers Health, Inc. (HIMS) Stock Forecast
HIMS analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.27 / 5 from 15 analysts
- Price target
- $31.15 average of analyst targets
- Upside to target
- +11.0% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $0.07
- 52-week range
- $14.52 – $51.36
HIMS analyst ratings
15 analystsNumber of analysts at each rating.
HIMS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HIMS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.06 | −$0.05 | $0.20 | $0.06 | −6.1% | 11 |
| Current fiscal year (2026) | −$0.56 | −$0.91 | −$0.01 | $0.51 | −209.9% | 11 |
| Next fiscal year (2027) | $0.42 | −$0.09 | $1.44 | −$0.56 | +174.8% | 11 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HIMS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $892.8M | $883.8M | $901.6M | +49.0% | 13 |
| Current fiscal year (2026) | $3.21B | $3.15B | $3.31B | +36.6% | 14 |
| Next fiscal year (2027) | $4.00B | $3.65B | $4.58B | +24.6% | 14 |
HIMS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HIMS revenue: reported and forecast
HIMS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | −6.2% | 0 up · 2 down |
| Current fiscal year (2026) | −$0.08 | −$0.46 | −$0.56 | −$0.56 | −$0.56 | +600.4% | 0 up · 2 down |
| Next fiscal year (2027) | $0.67 | $0.59 | $0.42 | $0.42 | $0.42 | −37.4% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HIMS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HIMS beat in 9 of 12.
What analysts expect from HIMS
15 analysts cover Hims & Hers Health; their consensus rating is hold (3.27 on a 1–5 scale, where 5 is a strong buy). The average price target is $31.15, 11.0% above the latest close of $28.07. Analysts expect earnings of −$0.56 per share for 2026, −209.9% from a year earlier. For 2027 the average estimate is $0.42 per share on revenue of $4.0 billion. Hims & Hers Health beat the EPS estimate in 9 of the last 12 quarters.
Related: HIMS income statement, HIMS key metrics, HIMS chart. See the HIMS stock overview for the latest quote and news.
HIMS forecast FAQ
What is Hims & Hers Health's price target?
The average analyst price target for Hims & Hers Health is $31.15, 11.0% above the latest close of $28.07.
Is Hims & Hers Health a buy, hold or sell?
Of 15 analysts covering Hims & Hers Health, 1 rate it a strong buy, 2 a buy, 12 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Hims & Hers Health's EPS forecast?
Analysts forecast −$0.56 per share for 2026 (range −$0.91 to −$0.01); for 2027 the estimate is $0.42.
What is Hims & Hers Health's revenue forecast?
The average revenue estimate for 2026 is $3.2 billion, growth of 36.6%; for 2027 it is $4.0 billion.
When does Hims & Hers Health report earnings?
Hims & Hers Health is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes; the EPS estimate is $0.07.
Does Hims & Hers Health usually beat earnings estimates?
Hims & Hers Health reported EPS at or above the analyst estimate in 9 of the last 12 quarters.